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Abstract
Background: Electroporation (EP) is a widely used non-viral gene transfer method. We have
attempted to develop an exact protocol to maximize DNA expression while minimizing tissue
damage following EP of skeletal muscle in vivo. Specifically, we investigated the effects of varying
injection techniques, electrode surface geometry, and plasmid mediums.
Results: We found that as the amount of damage increased in skeletal muscle in response to EP,
the level of β-galactosidase (β-gal) expression drastically decreased and that there was no evidence
of β-gal expression in damaged fibers. Two specific types of electrodes yielded the greatest amount
of expression. We also discovered that DNA uptake in skeletal muscle following intra-arterial
injection of DNA was significantly enhanced by EP. Finally, we found that DMSO and
LipoFECTAMINE™, common enhancers of DNA electroporation in vitro, had no positive effect on
DNA electroporation in vivo.
Conclusions: When injecting DNA intramuscularly, a flat plate electrode without any plasmid
enhancers is the best method to achieve high levels of gene expression.
Background
The field of gene therapy has great potential in terms of
therapeutic applications. The goal of this science is to
develop a method by which genes can be delivered to tis-
sue in vivo and produce high localized expression without
severe damaging effects. Recently, a novel gene therapy
technique has emerged that involves injection of naked
DNA coupled with electroporation (EP) [1,2].
During EP, a large voltage gradient is produced across the
muscle for a fraction of a second. This gradient produces
pores in the membranes of muscle cells, allowing extracel-
lular plasmids to enter the cell. The exact mechanisms of
this phenomenon are currently unknown. The amount of
gene expression is highly variable, depending upon elec-
trical parameters, plasmids, and injection methods. Addi-
tionally, EP can cause damage to the tissue resulting in
mineralized and hylanized necrosis. The amount of dam-
age the tissue experiences may be a function of the exact
method of EP. In the present research, we attempted to
develop an exact protocol to maximize gene expression
while minimizing expression variability and tissue
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damage. Specifically, this work investigated the effects of
injection techniques, electrode surface geometry, and
plasmid mediums.
Methods
Standardized electrical field parameters
A 2100 isolated pulse stimulator (AM-systems, Carlsborg,
WA) gating a GRASS S44 Solid State Wave Generator stim-
ulator (GRASS Instruments, Quincy, MA) connected to a
caliper electrode (BTX, San Diego, CA) was used to per-
form the EP. The thickness of the mouse's muscle was
measured by using the BTX caliper electrode and the elec-
trical parameters were adjusted accordingly to achieve a
voltage of 200 V/cm for 20 ms at 1 Hertz, as determined
previously by Mir et al to be an effective waveform for
naked DNA expression in mice undergoing EP [1]. The
mice were anesthetized with ketamine/xylazine (0.1 cc per
10 g body weight) before the DNA injection and EP. All
experimental mice were NIH Swiss Mice (Harlan, Indian-
apolis, IN) and received the same treatment unless other-
wise noted.
Whole tissue β-Gal assay
The muscle was prepared by a homogenizer (Brinkman,
Pittsburgh, PA) in potassium phosphate buffer with PMSF
and centrifuged at 3000 gs for 15 minutes. β-galactosidase
(β-gal) enzyme levels in the supernatant were assayed
with the Galacto-Star (Tropix, Foster City, CA) kit using a
Lumat LB 9507 luminometer (Berthhold Technologies,
Oak Ridge, TN). β-Gal activity was, therefore, reported in
relative light units. A standard curve for the luminescent
reaction was developed with known amounts of β-Gal
enzyme (Sigma, St. Louis, MO) and an equation relating
relative light units to β-Gal protein amount was deter-
mined and used to convert sample luminescence into mg
β-Gal protein by linear regression. The total amount of
protein in each muscle sample was also determined by a
DC Protein Assay Kit (Bio-Rad, Hercules, CA) and divided
into the β-Gal amounts to normalize the data and correct
for the different masses of the muscles. All the data are
reported as mean % β-Gal expression (average value of [β-
Gal activity (mg)/total protein (mg)]. All results were then
analyzed by Statistical Analysis Software (SAS, Cary, NC)
for continuous variables.
Damage assessment
Hemotaxlyin and Eosin (H&E) staining of light micro-
scopic sections was used to quantify the amount of dam-
age the muscle experienced due to EP. The gastrocnemius
of the mouse was embedded in O.C.T. compound (Tissue-
Tek, Torrance, CA) and frozen in liquid nitrogen. The tis-
sue was cross-sectioned using a cryostat (ThermoShan-
don, Pittsburg, PA) at -28°C. The slides were allowed to
dry and were then stained using H&E. The slides were cov-
erslipped by using Immunomount (ThermoShandon,
Pittsburgh, PA) and were photographed using a Leaf
microlumina mounted to a microscope (Olympus,
Melville, NY). After H&E staining, necrotic fibers appear
dark purple and are distinct from surrounding uninjured
fibers. By using Adobe Photoshop® (San Jose, CA) the area
of necrosis for each section was highlighted and the
number of pixels in this location was recorded. The total
area of each section was highlighted and the total number
of pixels was recorded. The area of necrosis was divided by
the total area of skeletal muscle tissue in the section. To
normalize the data, the amount of damage of each section
for each mouse was averaged to take in account the
expression variation between the proximal and distal por-
tion of the muscle.
Electrode geometry
After a 50 µl aliquot of saline containing 50 µg CMVLacZ
plasmid was injected into the right and left gastrocnemius
of the mice using a Hamilton syringe (Hamilton, Reno,
NV), four different electrodes were designed with varying
degrees of perforation in the plates (Figure 1). Both legs
were electroporated using one of the four different elec-
trodes (3 mice per electrode, Groups 4, 5, 6 and 7 in Table
1).
Histochemical staining
The mice were euthanized after 7 days and both gastroc-
nemius muscles were harvested. The left muscles were pre-
pared and assayed as described. The right gastrocnemius
of each mouse was embedded in O.C.T. compound and
frozen in liquid nitrogen. The tissue was cross-sectioned
using a cryostat at -28°. The slides were allowed to dry and
were then stained for LacZ activity using X-gal. The slides
were coverslipped by using Immunomount and photo-
graphed. By using Adobe Photoshop® the area of expres-
sion for each section was highlighted and the number of
pixels in this location was recorded. The total muscle area
of each section was highlighted and the total number of
pixels was recorded. The area of expression was divided by
the total muscle area of the section.
Intra-arterial and intramuscular injection
Fifty µl of sterile saline containing 50 ug of CMVLacZ con-
struct was injected into the right and left femoral arteries
of 4 NIH Swiss Mice (Harlan, Indianapolis, IN) using a
Hamilton syringe. The right limb was electroporated with
the BTX caliper flate plate electrode, while the left leg was
not (Table 1, Groups 1 and 2). The mice were euthanized
7 days later and the gastrocnemius muscle of each leg was
harvested. The muscles were prepared and the β-Galactos-
idase enzyme content was determined.
To compare intra-arterial injection (IA) and intramuscular
injection (IM), the same concentration of the same plas-
mid was injected into the right and left gastrocnemius ofBMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/11
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an additional 4 mice. The right limb was electroporated,
while the left leg was not (Table 1, Groups 3 and 4). The
mice were euthanized 7 days later and the gastrocnemius
muscle of each leg was harvested. The muscles were pre-
pared and the β-Galactosidase enzyme content was
determined.
LipoFECTAMINE and DMSO
The LipoFECTAMINE™ and the CMVLacZ plasmid were
combined at a 1:5 ratio and allowed to react for 6 hours
for optimal expression [3]. The plasmid/Lipo-
FECTAMINE™ solution was injected into the right and left
gastrocnemius of the mice using a Hamilton syringe. The
right limb was electroporated with the BTX caliper flat
plate electrode, while the left limb was not (Table 1,
Groups 9 and 10). The mice were euthanized after 7 days
and both gastrocnemius muscles were harvested. The
muscles were assayed.
A 50 µg sample of CMVLacZ plasmid was solubilized in a
sterile normal saline solution containing 1.25% DMSO.
This solution was injected into the right and left gastroc-
nemius of 7 Harlan mice using a Hamilton syringe. Only
the right limb was electroporated (Table 1, Group 8). The
mice were euthanized after 7 days and both gastrocne-
mius muscles were harvested. The muscles were prepared
and assayed.
Electrode Surface Geometry Figure 1
Electrode Surface Geometry. Four electrodes, labeled above, were tested on mice to determine the effect of surface 
geometry of DNA expression following electroporation into skeletal muscle.
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Results
Necrosis
We found that as the amount of muscles damage
(reported as percent necrosis) increased, the level of β-Gal
expression significantly decreased (Figure 2). A second
order polynomial was fit to the data with a correlation
coefficient of 0.826 (p < .01). Furthermore, there was no
evidence of β-Gal expression in damaged fibers (Figure 3).
Electrode geometry
The difference between electrode types is reported in
Table 1. With constant 200 V/cm voltage gradient shocks,
electrode A (group 4) and D (group 7) delivered the high-
est levels of B-gal activity, but were not significantly differ-
ent from one another (p < 0.17). Electrode A and
electrode D resulted in greater levels of expression, (p <
0.02) and (p < 0.01) respectively, than electrode C (group
6). Electrode D delivered higher levels of β-Gal activity (p
< 0.04) than electrode B (group 5). There was no statistical
difference between electrodes B and C. By using the H&E
staining, the level of damage was analyzed. When the
muscles were analyzed for damage, there was a trend for
greater damage with electrode D. However, there were no
statistically significant differences between the different
electrodes (Table 1).
Intra-arterial and intramuscular injection
There was no statistically significant difference in the β-
Gal expression levels of the muscles receiving IA and IM
injections (Table 1, group 1 and 3, respectively). Both IA
and IM injection followed by EP (groups 2 and 4, respec-
tively) produced significantly higher (p < 0.01) β-Gal
expression than the injection of naked DNA alone with-
out EP by either injection route (groups 1 and 3). When
expression levels of the mice that received IA injection fol-
lowed by EP (group 2) were compared to the expression
levels of mice that received IM injection followed by EP
(group 4), it was found that IM injection produced higher
levels of B-gal activity (p < 0.05). These results demon-
strate that EP indeed improved β-Gal expression levels
regardless of injection route, but IM injection of DNA
followed by EP is the most efficient method in producing
high levels of DNA expression.
LipoFECTAMINE and DMSO
Mice that received injection of CMVLacZ in Lipo-
FECTAMINE with EP (group 10) and mice that received
injection of CMVLacZ and LipoFECTAMINE without EP
(group 9) did not express β-Gal levels significantly higher
than background. In addition, there was no statistically
significant difference between the two groups (Table 1).
Table 1: Comparison of the different injection and electroporation techniques. Intramuscularly injected mice are represented as IM and 
intra-arterially injected mice are represented as IA. Mice that were electroporated are identified with a + sign and mice that were not 
electroporated are identified with a - sign. The four different electrode types are identified with letters that correspond to the letters 
in figure 3. a mean % β-Gal expression = average value of [β-Gal activity (mg)/total protein (mg)]. b,c,d,e,f,g statistical significance (p < .05) 
between groups with differing superscripts. n = 7 for each treatment group.
Group # Limb Injection EP Electrode Type Mean % β-Gal 
expressiona (+/- 
SD)
Mean % Area of 
Muscle Damage 
(+/- SD)
1 Left IA CMVLacZ in 
0.9% Saline
No EP No EP 0.0475b ± 0.0377
2 Right IA CMVLacZ in 
0.9% Saline
+A0 . 4 9 0 0 h ± 0.0200
3 Left IM CMVLacZ in 
0.9% Saline
No EP No EP 0.0200b ± 0.0082
4 Right IM CMVLacZ in 
0.9% Saline
+A7 . 7 9 0 c,e ± 4.5254 5.6 ± 4.9
5 Right IM CMVLacZ in 
0.9% Saline
+B5 . 0 4 c,d,f ± 2.4683 8.5 ± 4.9
6 Right IM CMVLacZ in 
0.9% Saline
+C3 . 6 1 6 7 d ± 2.2234 21.3 ± 6.1
7 Right IM CMVLacZ in 
0.9% Saline
+D1 1 . 6 5 0 e,g ± 3.0645 3.4 ± 4.9
8 Right IM CMVLacZ in 
1.25% DMSO
+A8 . 1 9 0 e,f,g ± 1.9986
9 Left IM CMVLacZ in 
LipoFECTAMINE
No EP No EP 0.0214b ± 0.0107
10 Right IM CMVLacZ in 
LipoFECTAMINE
+A0 . 0 4 1 4 b ± 0.1912BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/11
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Comparing the muscles that were injected with CMVLacZ
in 1.25% DMSO (group 8) and the muscles injected with
CMVLacZ in normal saline (group 3) demonstrated that
no significant difference existed between the groups
(Table 1).
Discussion
Tissue damage
We found that there was a decrease in β-Gal expression
with increasing muscle damage (Figure 2). Areas of the tis-
sue that experience damage and necrosis do not express
CMVLacZ because the fibers are dead (Figure 3). The dam-
age in Figure 3 is apparent because necrotic, mineralized
fibers appear opaque on phase-contrast microscopy and
gene expressing fibers appear blue due to the X-gal stain-
ing. Further investigation is required to find the optimum
voltage for maximal expression and minimal damage.
Ectopic DNA expression decreases with increasing tissue damage following electroporation Figure 2
Ectopic DNA expression decreases with increasing tissue damage following electroporation. LacZ expressing 
cDNA was electroporated into the gastrocnemius/soleus skeletal muscle. DNA expression was quantitated by measuring the 
amount of b-gal staining per area total muscle, and is reported as a percent of the gastrocnemius/soleus muscles. Tissue dam-
age was measured and is reported as a percent of damage per total gastrocnemius/soleus muscle area. A second order polyno-
mial was fitted to the data and it was found that there was a correlation coefficient of 0.826, which corresponds to a statistical 
significance of p < 0.01. This polynomial demonstrates that with increasing skeletal muscle damage, the amount of ectopic 
DNA expression decreases.
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Ectopic DNA expression following electroporation does not occur in damaged muscle fibers Figure 3
Ectopic DNA expression following electroporation does not occur in damaged muscle fibers. Micrograph above 
represents an example of a seriously injured muscle following electroporation. Blue fibers are cells that are expressing ectopic 
LacZ. Mineralized necrosis is apparent in the opaque, brown fibers. Ectopic DNA expression and muscle damage are mutually 
exclusive.BMC Biotechnology 2004, 4 http://www.biomedcentral.com/1472-6750/4/11
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Electrode geometry
For most EP, plate electrodes are used because these are
less invasive, easier to use and contact a larger area result-
ing in a greater distribution of expression. For our study,
plate electrodes were designed to decrease the actual sur-
face area contact by adding perforations of varying
number, size, spacing and geometry. The perforations
within a plate electrode will decrease actual surface area
contact and may decrease the total area of damage while
maintaining current flow over a larger area than a needle
point electrode. By choosing electrodes of this geometry,
it is intended that the area of tissue damage resulting from
electrode contact will be reduced while maintaining a
large area of current flow. By varying the surface geometry
of the electrodes, the current concentration geometry may
be changed in the muscle. We hypothesized that the dif-
ferent current patterns might cause increased expression
of β-Gal because DNA uptake is proportional to current
concentration. Additionally, Liu and Guang, reported that
tissue damage could be curtailed by decreasing the contact
points of the electrodes with the tissue [4]. In their study,
a syringe electrode was used to deliver the DNA and per-
form the EP [4]. A syringe electrode has only one contact
point with the tissue and this situation decreases the area
of the current flow, henceforth increasing current density
to this smaller area. Therefore, this electrode reduced the
amount of damage resulting from the procedure. How-
ever, the area of expression was also reduced. Our results
did not demonstrate a significant difference in the
amount of damage between plain or perforated elec-
trodes. However, our data demonstrated that the flat plate
electrode A (group 4) and electrode D (group 7) had the
highest mean level of expression. Therefore, either of
these two electrodes would be favorable for EP.
Intra-arterial and intramuscular injection
Zhang et al showed previously that IA injection of CMV-
LacZ into the femoral arteries of rats and monkeys
increased β-Gal activity in skeletal muscle [5]. It is sug-
gested that the artery transported the injected DNA
throughout the leg and into the cells. Zhang also sug-
gested that the increase in pressure from the injection
device causes the cell to porate [5]. We hypothesized that
combining EP with IA injection would greatly increase
expression levels of the injected DNA and better distribute
the expressed protein. Although IA injection with EP
increases the expression of β-Gal, it does not produce
more expression than IM injection. IA injection may be
promising in full dispersion of the CMVLacZ since the
blood will transport the DNA to most areas of the hind-
limb, but more volume of DNA and greater coverage of EP
would be needed. The advantage to using IA injection and
EP is that DNA can be delivered to a greater area, while IM
injection is localized to the injection site. Another advan-
tage to using the IA injection is that the procedure allows
for two mechanisms for extracellular DNA uptake. Recent
studies suggest that the blood transports the pDNA (~10
nm) to the cells and any molecule under 20–30 nm in size
will be consumed by the muscle endothelium [6]. The
mechanism for capillary delivery of macromolecules is
unclear, but it is proposed that it occurs through transcy-
tosis [7]. Our data demonstrated that IA injection of DNA
followed by EP increased expression in comparison to IA
injection alone. However, IM injection of DNA with EP
produced expression over 15 times that of IA injection
and EP. Further investigation and refinement of the IA
injection technique will be needed to fully develop its
potential.
LipoFECTAMINE and DMSO
DMSO is an amphillic compound that stabilizes the cell
membrane and it has been shown to increase transfection
efficiency in cultured cells [8]. We coupled DMSO with
the plasmid before injection into the muscle to determine
if it would increase DNA expression when EP followed the
injection. In our model, the addition of DMSO did not
increase expression in vivo as it does in vitro.
LipoFECTAMINE™ is a lipid that binds with DNA to make
it more lipophilic and, therefore, more likely to gain entry
into the cell [3]. It has been shown that combining Lipo-
FECTAMINE™ with CMVLacZ plasmid increases transfec-
tion in cell lines [3]. When LipoFECTAMINE was
combined with CMVLacZ and coupled with EP, it prohib-
ited β-Gal expression. The exact cause of it is currently
unknown. Recent studies have shown that Lipo-
FECTAMINE only works in a serum-free environment [3].
DOSPER, which is another lipophilic medium, has
proven to work in serum environments with comparable
expression as LipoFECTAMINE in the transfection of cell
lines [3]. Another cause of LipoFECTAMINE stopping
DNA transfer during electroporation is because the reac-
tion causes the CMVLacZ to become more lipophilic,
which in turn reduces the charge on the DNA. This lack of
charge may prohibit EP because EP may rely on the
extended portion of the 20 ms square wave to actually
drive the DNA into the cell. If the DNA were lacking any
charge, then the electroporation efficiency would be
greatly reduced, as seen by Table 1.
Conclusions
Our objective was to develop and refine a protocol to
maximize electroporated DNA expression in skeletal mus-
cle while minimizing tissue damage. Our data suggests
that when injecting DNA intramuscularly, a flat plate elec-
trode without any plasmid enhancers is the best method
yet tested for high levels of gene expression. In addition,
we found that ectopic expression of DNA within skeletal
muscle following IA injection is significantly enhanced by
EP. Finally, we observed that ectopic DNA expression andPublish with BioMed Central    and   every 
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muscle damage are mutually exclusive. Understanding
mechanisms of, and prevention of, muscle damage fol-
lowing EP could significantly enhance the efficiency of
DNA electroporation into skeletal muscle in vivo.
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